Elosulfase alfa API Manufacturers
compare suppliers & get competitive offers
Filters
Reset
Selected filters:
Type
Production region
Qualifications
To view suppliers for this material, you need to be logged in first.
This is because of international laws regarding narcotic materials. Furthermore, the contents of this page are only accessible if you are professionaly active in the pharmaceutical industry. In case you are, it is possible to register on our platform, and after your account is approved by our team you will be able to view suppliers and send your request.
Looking for Elosulfase alfa API 9025-60-9?
- Description:
- Here you will find a list of producers, manufacturers and traders of Elosulfase alfa. You can sort by certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.
- API | Excipient name:
- Elosulfase alfa
- Synonyms:
- N-acetylgalactosamine-6-sulfatase
- Cas Number:
- 9025-60-9
- DrugBank number:
- DB09051
- Unique Ingredient Identifier:
- ODJ69JZG85
About Elosulfase alfa
You can find a short description about Elosulfase alfa here. Elosulfase alfa is a synthetic version of the enzyme N-acetylgalactosamine-6-sulfatase. It was approved by the FDA in 2014 for the treatment of Morquio syndrome. Elosulfase alfa was developed by BioMarin Pharmaceutical Inc. and is marketed under the brand Vimizim™. The recommended dose is 2 mg per kg given intravenously over a minimum range of to hours, based on infusion volume, once every week.
You can ask the supplier for more technical information about the product.
